Standout Papers

The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets 2023 2026 202471
  1. The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets (2023)
    Kimberley El, Jonathan D. Douros et al. Nature Metabolism
  2. Transforming obesity: The advancement of multi-receptor drugs (2024)
    Christine M. Kusminski, Diego Pérez–Tilve et al. Cell

Immediate Impact

3 by Nobel laureates 27 from Science/Nature 73 standout
Sub-graph 1 of 17

Citing Papers

Dissociable hindbrain GLP1R circuits for satiety and aversion
2024 StandoutNature
Integrative neurocircuits that control metabolism and food intake
2023 StandoutScience
16 intermediate papers

Works of Diego Pérez–Tilve being referenced

Unimolecular Polypharmacy for Treatment of Diabetes and Obesity
2016
GLP-1 based therapeutics: simultaneously combating T2DM and obesity
2015
and 20 more

Author Peers

Author Last Decade Papers Cites
Diego Pérez–Tilve 2367 2446 1763 99 5.6k
Alessandro Pocai 2023 2210 1438 55 5.8k
Tony K.T. Lam 2478 3356 1466 104 7.0k
Paul T. Pfluger 2661 3131 980 98 6.7k
Françoise Rohner‐Jeanrenaud 3014 2681 991 97 6.1k
Jonathan B. Jaspan 1326 1618 1668 90 5.3k
Niels Vrang 4026 2662 2407 142 8.1k
Olga D. Carlson 1309 2420 1568 63 5.8k
Christoph Buettner 1050 2212 1279 68 5.6k
Timo D. Müller 1393 2218 2285 137 6.5k
David G. Parkes 1530 1288 2621 112 5.8k

All Works

Loading papers...

Rankless by CCL
2026